Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology
Aims/hypothesis Type 2 diabetes is associated with cognitive impairments, but it is unclear whether common genetic factors influence both type 2 diabetes risk and cognition. Methods Using data from 1892 Mexican-American individuals from extended pedigrees, including 402 with type 2 diabetes, we exam...
Gespeichert in:
Veröffentlicht in: | Diabetologia 2020-05, Vol.63 (5), p.977-986 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Aims/hypothesis
Type 2 diabetes is associated with cognitive impairments, but it is unclear whether common genetic factors influence both type 2 diabetes risk and cognition.
Methods
Using data from 1892 Mexican-American individuals from extended pedigrees, including 402 with type 2 diabetes, we examined possible pleiotropy between type 2 diabetes and cognitive functioning, as measured by a comprehensive neuropsychological test battery.
Results
Negative phenotypic correlations (
ρ
p
) were observed between type 2 diabetes and measures of attention (Continuous Performance Test [CPT d′]:
ρ
p
= −0.143,
p
= 0.001), verbal memory (California Verbal Learning Test [CVLT] recall:
ρ
p
= −0.111,
p
= 0.004) and face memory (Penn Face Memory Test [PFMT]:
ρ
p
= −0.127,
p
= 0.002; PFMT Delayed:
ρ
p
=
−0.148,
p
= 2 × 10
−
4
), replicating findings of cognitive impairment in type 2 diabetes. Negative genetic correlations (
ρ
g
) were also observed between type 2 diabetes and measures of attention (CPT d′:
ρ
g
= −0.401,
p
= 0.001), working memory (digit span backward test:
ρ
g
= −0.380,
p
= 0.005), and face memory (PFMT:
ρ
g
= −0.476,
p
= 2 × 10
−
4
; PFMT Delayed:
ρ
g
= −0.376,
p
= 0.005), suggesting that the same genetic factors underlying risk for type 2 diabetes also influence poor cognitive performance in these domains. Performance in these domains was also associated with type 2 diabetes risk using an endophenotype ranking value approach. Specifically, on measures of attention (CPT d′:
β
= −0.219,
p
= 0.005), working memory (digit span backward:
β
= −0.326,
p
= 0.035), and face memory (PFMT:
β
= −0.171,
p
= 0.023; PFMT Delayed:
β
= −0.215,
p
= 0.005), individuals with type 2 diabetes showed the lowest performance, while unaffected/unrelated individuals showed the highest performance, and those related to an individual with type 2 diabetes performed at an intermediate level.
Conclusions/interpretation
These findings suggest that cognitive impairment may be a useful endophenotype of type 2 diabetes and, therefore, help to elucidate the pathophysiological underpinnings of this chronic disease.
Data availability
The data analysed in this study is available in dbGaP:
www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001215.v2.p2
. |
---|---|
ISSN: | 0012-186X 1432-0428 |
DOI: | 10.1007/s00125-020-05101-y |